Feb. 21 at 12:41 PM
$CVALF nice Q4 earnings of .04. Growth still occurring. Floor FV of
$3.20. But I think they can do .24 in 2025. At 20x this is
$4.80.
Company noted headwinds on collagen, but will flip in H2 2025.
Let’s see what mkt thinks about this one today.